Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

Amelioration of the nigrostriatal pathway facilitated by ultrasound-mediated neurotrophic delivery in early Parkinson's disease.

Karakatsani ME, Wang S, Samiotaki G, Kugelman T, Olumolade OO, Acosta C, Sun T, Han Y, Kamimura HAS, Jackson-Lewis V, Przedborski S, Konofagou E.

J Control Release. 2019 Jun 10;303:289-301. doi: 10.1016/j.jconrel.2019.03.030. Epub 2019 Apr 4.

PMID:
30953664
2.

Identification of neurodegenerative factors using translatome-regulatory network analysis.

Brichta L, Shin W, Jackson-Lewis V, Blesa J, Yap EL, Walker Z, Zhang J, Roussarie JP, Alvarez MJ, Califano A, Przedborski S, Greengard P.

Nat Neurosci. 2015 Sep;18(9):1325-33. doi: 10.1038/nn.4070. Epub 2015 Jul 27.

3.

α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.

Kett LR, Stiller B, Bernath MM, Tasset I, Blesa J, Jackson-Lewis V, Chan RB, Zhou B, Di Paolo G, Przedborski S, Cuervo AM, Dauer WT.

J Neurosci. 2015 Apr 8;35(14):5724-42. doi: 10.1523/JNEUROSCI.0632-14.2015.

4.

Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit.

Gonzalez-Reyes LE, Verbitsky M, Blesa J, Jackson-Lewis V, Paredes D, Tillack K, Phani S, Kramer ER, Przedborski S, Kottmann AH.

Neuron. 2012 Jul 26;75(2):306-19. doi: 10.1016/j.neuron.2012.05.018.

5.

Classic and new animal models of Parkinson's disease.

Blesa J, Phani S, Jackson-Lewis V, Przedborski S.

J Biomed Biotechnol. 2012;2012:845618. doi: 10.1155/2012/845618. Epub 2012 Mar 28. Review.

6.

Animal models of Parkinson's disease.

Jackson-Lewis V, Blesa J, Przedborski S.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S183-5. doi: 10.1016/S1353-8020(11)70057-8. Review.

PMID:
22166429
7.

Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease.

Lim L, Jackson-Lewis V, Wong LC, Shui GH, Goh AX, Kesavapany S, Jenner AM, Fivaz M, Przedborski S, Wenk MR.

Cell Death Differ. 2012 Mar;19(3):416-27. doi: 10.1038/cdd.2011.105. Epub 2011 Aug 5.

8.

Control of mitochondrial integrity in Parkinson's disease.

Vives-Bauza C, Tocilescu M, Devries RL, Alessi DM, Jackson-Lewis V, Przedborski S.

Prog Brain Res. 2010;183:99-113. doi: 10.1016/S0079-6123(10)83006-7.

PMID:
20696317
9.

Apoptosis-inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins.

Perier C, Bové J, Dehay B, Jackson-Lewis V, Rabinovitch PS, Przedborski S, Vila M.

Ann Neurol. 2010 Aug;68(2):184-92. doi: 10.1002/ana.22034.

PMID:
20695011
10.

Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.

Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, Greene LA.

J Neurosci. 2010 Jan 20;30(3):1166-75. doi: 10.1523/JNEUROSCI.3944-09.2010.

11.

Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.

Zhang W, Phillips K, Wielgus AR, Liu J, Albertini A, Zucca FA, Faust R, Qian SY, Miller DS, Chignell CF, Wilson B, Jackson-Lewis V, Przedborski S, Joset D, Loike J, Hong JS, Sulzer D, Zecca L.

Neurotox Res. 2011 Jan;19(1):63-72. doi: 10.1007/s12640-009-9140-z. Epub 2009 Dec 3.

12.

Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease.

Hoang T, Choi DK, Nagai M, Wu DC, Nagata T, Prou D, Wilson GL, Vila M, Jackson-Lewis V, Dawson VL, Dawson TM, Chesselet MF, Przedborski S.

Free Radic Biol Med. 2009 Oct 1;47(7):1049-56. doi: 10.1016/j.freeradbiomed.2009.07.013. Epub 2009 Jul 17.

13.

Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.

Li Y, Liu W, Oo TF, Wang L, Tang Y, Jackson-Lewis V, Zhou C, Geghman K, Bogdanov M, Przedborski S, Beal MF, Burke RE, Li C.

Nat Neurosci. 2009 Jul;12(7):826-8. doi: 10.1038/nn.2349. Epub 2009 Jun 7.

14.

The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.

Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K.

Proc Natl Acad Sci U S A. 2009 May 12;106(19):8043-8. doi: 10.1073/pnas.0900358106. Epub 2009 Apr 29.

15.

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Banerjee R, Mosley RL, Reynolds AD, Dhar A, Jackson-Lewis V, Gordon PH, Przedborski S, Gendelman HE.

PLoS One. 2008 Jul 23;3(7):e2740. doi: 10.1371/journal.pone.0002740.

16.

Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease.

Perier C, Bové J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V, Rathke-Hartlieb S, Bouillet P, Strasser A, Schulz JB, Przedborski S, Vila M.

Proc Natl Acad Sci U S A. 2007 May 8;104(19):8161-6. Epub 2007 May 2.

17.

Protocol for the MPTP mouse model of Parkinson's disease.

Jackson-Lewis V, Przedborski S.

Nat Protoc. 2007;2(1):141-51.

PMID:
17401348
18.

Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice.

Rojo AI, Montero C, Salazar M, Close RM, Fernández-Ruiz J, Sánchez-González MA, de Sagarra MR, Jackson-Lewis V, Cavada C, Cuadrado A.

Eur J Neurosci. 2006 Oct;24(7):1874-84.

PMID:
17067291
20.

Proteasome inhibition and Parkinson's disease modeling.

Bové J, Zhou C, Jackson-Lewis V, Taylor J, Chu Y, Rideout HJ, Wu DC, Kordower JH, Petrucelli L, Przedborski S.

Ann Neurol. 2006 Aug;60(2):260-4.

PMID:
16862585

Supplemental Content

Loading ...
Support Center